Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world Benvitimod Cream for Chronic Simple Lichen
ChiCTR2500096856Phase 4Recruiting
- Sponsor
- Taizhou Central Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tapinarof in neurodermatitis (2 arms), sponsored by Taizhou Central Hospital. Primary endpoint: Total skin lesion symptom score (TSS). Started Feb 2025; status: recruiting.
02
Drugs
tapinarof
03
Conditions
neurodermatitis
Beyond the preview
Go deeper on ChiCTR2500096856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096856.